A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students

Journal of American College Health

Volumn 64, Issue 4, 2016, Pages 269-278

  Richman, Alice R ^a   Maddy, LaDonna ^a   Torres, Essie ^a   Goldberg, Ellen J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

College students; human papillomavirus vaccine; reminder systems; text e mail messaging

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; FEMALE; HUMAN; MALE; NORTH CAROLINA; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRUS INFECTIONS; PSYCHOLOGY; REMINDER SYSTEM; STANDARDS; STATISTICS AND NUMERICAL DATA; STUDENT; TEXT MESSAGING; UNIVERSITY; UTILIZATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; NORTH CAROLINA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; REMINDER SYSTEMS; STUDENTS; TEXT MESSAGING; UNIVERSITIES;

EID: 84961199078     PISSN: 07448481     EISSN: 19403208     Source Type: Journal    
DOI: 10.1080/07448481.2015.1117466     Document Type: Article

References (26)

1. D.Saslow, D.Solomon, H.W.Lawson, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–172.
2. B.E.Hoots, J.M.Palefsky, J.M.Pimenta, Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124:2375–2383.
3. A.R.Kreimer, G.M.Clifford, P.Boyle, Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–475.
4. M.L.Gillison, L.D.R.Chaturvedi,AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113:3036–3046.
5. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:626–629.
6. E.A.Joura, A.R.Giuliano, O.E.Iversen, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372:711–723.
7. L.E.Markowitz, E.F.Dunne, M.Saraiya, Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunizations Practices (ACIP). MMWR Recomm Rep. 2007;56(RR02):1–24.
8. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from ACIP. MMWR Morb Mortal Wkly Rep. 2010;59:630–632.
9. Food and Drug Administration. FDA news release: FDA: Gardasil approved to prevent anal cancer. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm237941.htm. Accessed January 7, 2011.
10. Centers for Disease Control and Prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendation of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–304.
11. Centers for Disease Control and Prevention. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:625–633.
12. N.Jain, G.L.Euler, A.Shefer, Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007. Prev Med. 2009;48:426–431.
13. Centers for Disease Control and Prevention. Vaccination coverage among adults, excluding influenza vaccination—Unites States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:95–102.
14. L.E.Widdice, D.I.Bernstein, A.C.Leonard, Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127:77–84.
15. L.M.Kester, R.B.Shedd-Steele, C.A.Dotson-Roberts, The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18–26 year old young adults. Gynecol Oncol. 2014;132:S9–S12.
16. American Cancer Society. Cancer Facts & Figures 2014 Web site. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/. Accessed June 2, 2014.
17. T.J.Herzog, W.K.Huh, L.S.Downs, Initial lessons learned in HPV vaccination. Gynecol Oncol. 2008;109:S4–S11.
18. E.C.Matheson, A.Derouin, M.Gagliano, Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2013;28:e35–e39.
19. A.Patel, L.Stern, Z.Unger,, Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine. 2014;32:2428–2433.
20. E.O.Kharbanda, M.S.Stockwell, H.W.Fox, R.Andres, M.Lara, V.I.Rickert. Text message reminders to promote human papillomavirus vaccination. Vaccine. 2011;29:2537–2541.
21. C.M.Rand, H.Brill, C.Albertin, Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents. J Adolesc Health. 2015;56(5 Suppl):S17–S20.
22. P.G.Szilagyi, C.Albertin, S.G.Humiston, A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr. 2013;13:204–213.
23. C.A.Suh, A.Saville, M.F.Daley, Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012;129:e1437–e1445.
24. B.Cassidy, B.Braxter, D.Charron-Prochownik, E.A.Schlenk. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care. 2014;28:155–164.
25. E.G.Stone, S.C.Morton, M.E.Hulscher, Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002;136:641–651.
26. Health Information National Trends Survey (HINTS) Web site. Available at: http://hints.cancer.gov/. Accessed January 15, 2011.